Thursday, February 22, 2024
spot_img

FDA warns of contaminated copycat eye drops


The Food and Drug Administration is warning the public against copycat eye drops because of the risk of infection.

South Moon, Rebright and FivFivGo eye drops come in packaging that could easily be confused with Bausch + Lomb’s brand Limify eye drops, an over-the-counter product approved for relief of redness, the FDA announced Wednesday.

The copied products claim to treat conditions such as glaucoma, which is treated with prescription drugs or surgery, the agency noted.

Product photo of eye drops copied from South Moon.

Food and Drug Administration


The FDA tested samples of South Moon and Rebright eye drops purchased online, and found the former to be contaminated with Burkholderia cepacia complex, a group of bacteria that can cause an antibiotic-resistant infection. Although Rebright testing did not reveal contamination, the agency recommended against its use.

FDA testing also found that South Moon and Rebright drops lacked brimonidine tartrate, the active ingredient in Limify. The agency was unable to obtain FivFivGo samples.

lumify.png
Image of authentic Limify eye drops.

Food and Drug Administration


The origin of the copied products is not yet clear, but the federal agency continues to investigate.

The FDA has received reports of possibly fake Lumify, including quality issues, eye irritation, pain and infections, according to the agency, which advised eye drop users to only purchase products from reputable retailers, such as state-licensed pharmacies.

The warning comes just months after an eye drop recall in which 28 products were removed from store shelves due to safety concerns sparked by investigators uncovering unsanitary conditions at a manufacturing plant in India. This November recall was one of eight separate announcements related to the eye drops last year.

The wave of eye drop product recalls last year was linked to four deaths and several cases of vision loss.



Note: The content and images used in this article is rewritten and sourced from www.cbsnews.com

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Most Trending